Considering the article mentions ReCET and semaglutide, presumably most people in the study weren't resuming the unhealthy diet.

Semaglutide is ozempic. By itself it can be enough to help people get their A1C down through healthier diets.

For me to find the study especially interesting, I'd have to see a comparison between ReCET + semaglutide vs just semaglutide. And upon re-reading I see that's their plan.

> “We are currently conducting the EMINENT-2 trial with the same inclusion and exclusion criteria and administration of semaglutide, but with either a sham procedure or ReCET. This study will also include mechanistic assessments to evaluate the underlying mechanism of ReCET.”